Pages that link to "Q36450877"
Jump to navigation
Jump to search
The following pages link to Intensity-modulated radiation therapy, protons, and the risk of second cancers (Q36450877):
Displaying 50 items.
- A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction (Q24567501) (← links)
- Risk factors for subsequent endocrine-related cancer in childhood cancer survivors (Q26745707) (← links)
- A Review of Radiotherapy-Induced Late Effects Research after Advanced Technology Treatments (Q26767255) (← links)
- Secondary Malignancy Risk Following Proton Radiation Therapy (Q26774492) (← links)
- The Impact of Neutrons in Clinical Proton Therapy (Q26777844) (← links)
- Concepts and challenges in cancer risk prediction for the space radiation environment (Q26800463) (← links)
- The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future (Q26829528) (← links)
- Fluorescent imaging of cancerous tissues for targeted surgery (Q26830905) (← links)
- Second malignant neoplasms and cardiovascular disease following radiotherapy (Q26864522) (← links)
- Comparing planning time, delivery time and plan quality for IMRT, RapidArc and Tomotherapy (Q28264970) (← links)
- Basics of particle therapy I: physics (Q28728202) (← links)
- Current role of modern radiotherapy techniques in the management of breast cancer (Q28972351) (← links)
- Comparison of Two RapidArc Delivery Strategies in Stereotactic Body Radiotherapy of Peripheral Lung Cancer with Flattening Filter Free Beams (Q29248456) (← links)
- Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. (Q30368547) (← links)
- Radiation techniques in neuro-oncology (Q30371425) (← links)
- Fractionated stereotactic radiotherapy of benign skull-base tumors: a dosimetric comparison of volumetric modulated arc therapy with Rapidarc® versus non-coplanar dynamic arcs. (Q30385571) (← links)
- Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada? (Q30428790) (← links)
- Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base (Q33273283) (← links)
- Charged particles in radiation oncology (Q33273594) (← links)
- Proton radiotherapy: the biological effect of treating alternating subsets of fields for different treatment fractions (Q33273883) (← links)
- Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol (Q33275243) (← links)
- Spot scanning proton therapy minimizes neutron dose in the setting of radiation therapy administered during pregnancy (Q33276221) (← links)
- Scan pattern optimization for uniform proton beam scanning (Q33502289) (← links)
- Hybrid computational phantoms for medical dose reconstruction (Q33521035) (← links)
- Assessment of out-of-field absorbed dose and equivalent dose in proton fields (Q33579632) (← links)
- Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma: dosimetric comparison and risk assessment of solid secondary cancer (Q33583912) (← links)
- Dosimetric advantage of volumetric modulated arc therapy in the treatment of intraocular cancer (Q33655585) (← links)
- Radiation-induced bystander signalling in cancer therapy (Q33794726) (← links)
- Assessing the risk of second malignancies after modern radiotherapy (Q33914324) (← links)
- Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer (Q33998022) (← links)
- Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams (Q34081025) (← links)
- The risk of developing a second cancer after receiving craniospinal proton irradiation (Q34086830) (← links)
- Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer (Q34086854) (← links)
- Influence of beam efficiency through the patient-specific collimator on secondary neutron dose equivalent in double scattering and uniform scanning modes of proton therapy (Q34126066) (← links)
- Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer (Q34246244) (← links)
- IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal (Q34372829) (← links)
- Cancer radiotherapy based on femtosecond IR laser-beam filamentation yielding ultra-high dose rates and zero entrance dose (Q34395071) (← links)
- An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy (Q34402663) (← links)
- Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report (Q34418908) (← links)
- Doses to internal organs for various breast radiation techniques--implications on the risk of secondary cancers and cardiomyopathy. (Q34521998) (← links)
- Current status of radiotherapy with proton and light ion beams (Q34576474) (← links)
- Radiation-induced sarcomas of the head and neck (Q34657771) (← links)
- Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans (Q34666728) (← links)
- Bystander effects and radiotherapy (Q34719561) (← links)
- Minimizing second cancer risk following radiotherapy: current perspectives (Q34757180) (← links)
- Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer (Q34871906) (← links)
- Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries (Q34914474) (← links)
- Which T category of nasopharyngeal carcinoma may benefit most from volumetric modulated arc therapy compared with step and shoot intensity modulated radiation therapy (Q35005542) (← links)
- Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview (Q35005607) (← links)
- The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer (Q35034618) (← links)